Financials

  • Market Capitalization 10.59 M
  • Employee 39
  • Founded 2016
  • CEO N/A
  • Website www.sentibio.com
  • Headquarter Delaware, United States
  • FIGI BBG021Y8RQQ5
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.56
Price to sales ratio

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4726
CMMB
Chemomab Therapeutics Ltd - American Depositary Shares
1.55 USD+1.31%+10.71%-11.43%+5.08%11.15 M USD
4732
GDTC
CytoMed Therapeutics Limited - Ordinary Shares
0.93 USD-6.06%-2.11%-1.06%-46.86%11.00 M USD
4744
GTBP
GT Biopharma, Inc. - Common Stock
0.29 USD-6.45%-12.12%-42.00%-82.94%10.46 M USD
4749
INAB
IN8bio, Inc. - Common Stock
1.04 USD-3.70%-15.45%-28.77%-37.72%10.24 M USD

Frequently asked questions about Senti Biosciences, Inc. - Common Stock

What is the Senti Biosciences, Inc. - Common Stock stock price today?

The current price of Senti Biosciences, Inc. - Common Stock (SNTI) is 0.34. Over the past 24 hours, the stock has changed by -5.56%. Follow the SNTI chart for real-time price dynamics.

What is the stock ticker of Senti Biosciences, Inc. - Common Stock?

Senti Biosciences, Inc. - Common Stock trades under the ticker SNTI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Senti Biosciences, Inc. - Common Stock stock going up?

SNTI has changed by -15.00% over the last week, -68.52% over the last month, and -64.29% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Senti Biosciences, Inc. - Common Stock?

Senti Biosciences, Inc. - Common Stock currently has a market capitalization of 10.59 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Senti Biosciences, Inc. - Common Stock earnings last quarter?

Last quarter, Senti Biosciences, Inc. - Common Stock reported earnings of -0.14 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Senti Biosciences, Inc. - Common Stock revenue for the last quarter?

Senti Biosciences, Inc. - Common Stock reported quarterly revenue of 16 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Senti Biosciences, Inc. - Common Stock net income for the last quarter?

Senti Biosciences, Inc. - Common Stock reported net income of -4.22 M for the last quarter. The previous quarter showed -14.47 M, which means net income changed by +70.82%.

How many employees does Senti Biosciences, Inc. - Common Stock have?

As of the latest available data, Senti Biosciences, Inc. - Common Stock has 39 employees. Workforce size can provide additional context about the company's scale and operations.

What is Senti Biosciences, Inc. - Common Stock EBITDA?

Senti Biosciences, Inc. - Common Stock EBITDA is -3.93 M, and its EBITDA margin is -24.55 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Senti Biosciences, Inc. - Common Stock stock?

You can buy Senti Biosciences, Inc. - Common Stock (SNTI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Senti Biosciences, Inc. - Common Stock stock?

Investing in Senti Biosciences, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SNTI chart and related analysis on metatrader.com as part of your research.

News